Logo image of CNTB

CONNECT BIOPHARMA HOLDINGS L (CNTB) Stock Analyst Ratings

NASDAQ:CNTB - Nasdaq - US2075231017 - ADR - Currency: USD

0.7392  -0.09 (-10.94%)

After market: 0.77 +0.03 (+4.17%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to CNTB. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 8.16. This target is 1003.9% above the current price.
CNTB was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about CNTB.
In the previous month the buy percentage consensus was at a similar level.
CNTB was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

CNTB Historical Analyst RatingsCNTB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -47 -43 -39 -35 -31 -27 -23 -19 -15 -11 -7 -3 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 0.748.088.168.168.40 - 993.07% 1,003.90% 1,003.90% 1,036.36%

Related screens

CNTB Current Analyst RatingCNTB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-04-01 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-31 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-17 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-04 HC Wainwright & Co. Initiate Buy
2023-09-13 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-02-08 SVB Leerink Maintains Outperform
2022-06-02 Cantor Fitzgerald Initiate Overweight
2022-05-05 Piper Sandler Downgrade Overweight -> Neutral
2022-05-04 SVB Leerink Maintains Outperform
2022-01-06 SVB Leerink Maintains Outperform
2021-07-02 CICC Initiate Outperform
2021-04-13 SVB Leerink Initiate Outperform
2021-04-13 Jefferies Initiate Buy